S. Markovic‐Plese

发表

Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.

Fumiaki Tanaka, K. Fischbeck, J. Taylor, 2003, Human molecular genetics.

Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing‐remitting multiple sclerosis

Yasheng Chen, Weili Lin, D. Shen, 2013, Human brain mapping.

Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy

V. Jewells, W. Royal, S. Markovic‐Plese, 2011, Journal of NeuroVirology.

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study

D. Ramasamy, M. Dwyer, R. Zivadinov, 2014, PloS one.

Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing–remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly

M. Dwyer, R. Zivadinov, B. Weinstock-Guttman, 2015, Journal of Neuroimmunology.

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS

D. Ramasamy, M. Dwyer, R. Zivadinov, 2015, Neurology: Neuroimmunology & Neuroinflammation.

IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Y. Shih, B. Midkiff, V. Jewells, 2018, Clinical immunology.

STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways

J. Ting, K. Ainslie, W. Chou, 2021, The Journal of Immunology.

T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans

A. Sette, D. Hafler, V. Kuchroo, 1994, Journal of Neuroimmunology.

A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.

Yonggang Sha, S. Markovic‐Plese, S. Markovic-Plese, 2011, Self/nonself.

This information is current as Remitting Multiple Sclerosis − Relapsing in β B Cells as a Therapeutic Target for IFN -

Yonggang Sha, S. Markovic‐Plese, M. Chopra, 2011 .

Regulation of Suppressors of Cytokine Signaling as a Therapeutic Approach in Autoimmune Diseases, with an Emphasis on Multiple Sclerosis

S. Markovic‐Plese, V. Ramgolam, S. Markovic-Plese, 2011, Journal of signal transduction.

Multiple Sclerosis T Cells Derived from Patients with + CD4Expression and Th17 Cell Differentiation in Simvastatin Inhibits IFN Regulatory Factor 4

S. Markovic‐Plese, L. Troiani, Yazhong Tao, 2011 .

IFN-β Inhibits Human Th17 Cell Differentiation1

Jianping Jin, Yonggang Sha, S. Markovic‐Plese, 2009, The Journal of Immunology.

IFN- Inhibits Human Th17 Cell Differentiation

Jianping Jin, Yonggang Sha, S. Markovic‐Plese, 2009 .

Acute disseminated encephalomyelitis after liver transplantation.

S. Markovic‐Plese, E. Lindzen, A. Gilani, 2005, Archives of neurology.

Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder

N. Chahin, V. Jewells, S. Markovic‐Plese, 2015, Journal of Neuroimmunology.

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

H. Weiner, D. Hafler, Jingwu Z. Zhang, 1994, The Journal of experimental medicine.

Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

T. Waldmann, J. Frank, Roland Martin, 2004 .

Dendritic cells signal T cells in the absence of exogenous antigen

Roland Martin, I. Cortese, T. Kondo, 2001, Nature Immunology.

The initiation of the autoimmune response in multiple sclerosis

C. Pinilla, Roland Martin, S. Markovic‐Plese, 2004, Clinical Neurology and Neurosurgery.

The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis

Hongtu Zhu, Yunan Tang, V. Jewells, 2014, The Journal of Immunology.

IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation1

Jianping Jin, Yunan Tang, S. Markovic‐Plese, 2009, The Journal of Immunology.

Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

Jianping Jin, D. Armao, D. Laplaud, 2009, Clinical immunology.

Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response

S. Markovic‐Plese, Xin Zhang, S. Markovic-Plese, 2008, Immunologic research.

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

V. Durkalski, T. Vollmer, L. Key, 2004, The Lancet.

Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands1

R Simon, C. Pinilla, B. Hemmer, 2001, The Journal of Immunology.

Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection

C. Hall, K. Robertson, S. Markovic‐Plese, 2011, Journal of NeuroVirology.

Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing–Remitting Multiple Sclerosis

Hongtu Zhu, Mihye Ahn, S. Markovic‐Plese, 2013, The Journal of Immunology.

Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.

R. Simon, C. Pinilla, B. Hemmer, 2001, Journal of autoimmunity.

IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis

Jianping Jin, Yunan Tang, J. Drulovic, 2015, The Journal of Immunology.

Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.

M. Freedman, J. Kaplan, S. Markovic‐Plese, 2013, Journal of clinical & cellular immunology.

Pathogenic features of CD4+CD28- T cells in immune disorders.

N. Hellings, P. Stinissen, S. Markovic‐Plese, 2012, Trends in molecular medicine.

Degenerate T-Cell Receptor Recognition, Autoreactive Cells, and the Autoimmune Response in Multiple Sclerosis

S. Markovic‐Plese, S. Markovic-Plese, 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

Multiple Sclerosis Degenerate T-Cell Receptor Recognition , Autoreactive Cells , and the Autoimmune Response in

S. Markovic‐Plese, S. Markovic-Plese, 2009 .

Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes

Jianping Jin, S. Markovic‐Plese, Xueyan Peng, 2008, The Journal of Immunology.

Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.

I. Singh, Avtar K. Singh, S. Markovic‐Plese, 2008, Future neurology.

CD4+CD28- costimulation-independent T cells in multiple sclerosis.

H. McFarland, R. Martin, I. Cortese, 2001, The Journal of clinical investigation.

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing–remitting multiple sclerosis

S. Markovic‐Plese, Xin Zhang, S. Markovic-Plese, 2010, Clinical Neurology and Neurosurgery.

Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis.

S. Markovic‐Plese, V. Ramgolam, S. Markovic-Plese, 2010, Endocrine, metabolic & immune disorders drug targets.

Remitting Multiple Sclerosis − Antibody ) in Patients with Relapsing Alemtuzumab ( Anti-CD 52 Monoclonal following Immunodepleting Treatment with Differential Reconstitution of T Cell Subsets

Hongtu Zhu, Mihye Ahn, S. Markovic‐Plese, 2013 .

High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis

R. Simon, C. Pinilla, Roland Martin, 2005, Journal of Neuroimmunology.

Molecular Mimicry in Neurological Diseases

S. Markovic‐Plese, S. Markovic-Plese, 2000 .

The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.

Y. Wan, Ping Li, Jian-liang Li, 2021, Immunity.

Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis

Yonggang Sha, S. Markovic‐Plese, S. Markovic-Plese, 2016, Front. Immunol..

Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis

S. Markovic‐Plese, L. Troiani, Yazhong Tao, 2011, The Journal of Immunology.

T Cell LFA-1 Engagement Induces HuR-Dependent Cytokine mRNA Stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 Signaling Cascade

R. Pardi, J. Bender, S. Markovic‐Plese, 2010, PloS one.

Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis

Jianping Jin, Shailendra Giri, S. Markovic‐Plese, 2006, Journal of Neuroimmunology.

Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)

S. Markovic‐Plese, Yazhong Tao, Xin Zhang, 2016, Journal of Neuroimmunology.

Immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testing

S. Markovic‐Plese, Jessica Craddock, S. Markovic-Plese, 2015, Expert review of clinical pharmacology.

B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis

Yonggang Sha, S. Markovic‐Plese, M. Chopra, 2011, The Journal of Immunology.

Functional HLA‐DM on the surface of B cells and immature dendritic cells

Dirk Schadendorf, Gerhard Moldenhauer, Yuansheng Sun, 2000, The EMBO journal.

CD 4 + CD 28 – costimulation-independent T cells in multiple sclerosis

Roland Martin, H. McFarland, I. Cortese, 2001 .

Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: Implications for the initiation of the autoimmune response in multiple sclerosis

C. Pinilla, M. Sospedra, Roland Martin, 2008, European journal of immunology.

CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.

P. Geusens, N. Hellings, P. Stinissen, 2012, Journal of autoimmunity.

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.

T. Waldmann, J. Frank, Roland Martin, 2004, Proceedings of the National Academy of Sciences of the United States of America.

The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.

Sarah C. Rogan, K. Blauth, S. Markovic‐Plese, 2015, Clinical immunology.

Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys.

P. Kaufman, V. Choi, R. Samulski, 2010, Investigative ophthalmology & visual science.

Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells

S. Markovic‐Plese, Y. Wan, B. Wu, 2022, The Journal of Immunology.

Alemtuzumab (Anti-CD52 mAb) Induces Expansion of Treg and Th2 Cells and Inhibits Th1 and Th17 Cells in Treated Patients with Relapsing Remitting Multiple Sclerosis (RRMS) (P02.119)

S. Markovic‐Plese, M. Chopra, L. Troiani, 2012 .

IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

R. Sobel, S. Markovic‐Plese, Stephanie M. Cohen, 2019, The Journal of Immunology.

Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate

C. Lucchinetti, W. Brück, R. Gold, 2012, Annals of neurology.

Simvastatin inhibits secretion of Th17‐polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis

S. Markovic‐Plese, R. García-Mata, Yazhong Tao, 2013, European journal of immunology.

Immunopathogenesis of the multiple sclerosis lesion

H. McFarland, S. Markovic‐Plese, S. Markovic-Plese, 2001, Current neurology and neuroscience reports.